title: Tumour-stromal interactions in acid-mediated invasion: a mathematical model.
abstract: It is well established that the tumour microenvironment can both promote and suppress tumour growth and invasion, however, most mathematical models of invasion view the normal tissue as inhibiting tumour progression via immune modulation or spatial constraint. In particular, the production of acid by tumour cells and the subsequent creation of a low extracellular pH environment has been explored in several 'acid-mediated tumour invasion' models where the acidic environment facilitates normal cell death and permits tumour invasion. In this paper, we extend the acid-invasion model developed by Gatenby and Gawlinski (1996) to include both the competitive and cooperative interactions between tumour and normal cells, by incorporating the influence of extracellular matrix and protease production at the tumour-stroma interface. Our model predicts an optimal level of tumour acidity which produces both cell death and matrix degradation. Additionally, very aggressive tumours prevent protease production and matrix degradation by excessive normal cell destruction, leading to an acellular (but matrix filled) gap between the tumour and normal tissue, a feature seen in encapsulated tumours. These results suggest, counterintuitively, that increasing tumour acidity may, in some cases, prevent tumour invasion.
authors.affiliation: Centre for Mathematical Biology, Mathematical Institute, Oxford University, 24-29 St Giles', Oxford OX1 3LB, UK. natasha.martin@bristol.ac.uk
authors.forename: Natasha K
authors.initials: NK
authors.lastname: Martin
authors.forename: Eamonn A
authors.initials: EA
authors.lastname: Gaffney
authors.forename: Robert A
authors.initials: RA
authors.lastname: Gatenby
authors.forename: Philip K
authors.initials: PK
authors.lastname: Maini
mesh_terms: D000465:Algorithms; D000818:Animals; D016923:Cell Death / Q000502:physiology; D003198:Computer Simulation; D003238:Connective Tissue / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D045726:Metalloproteases / Q000378:metabolism; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism; D059016:Tumor Microenvironment / Q000502:physiology*
chemical_list: D045726:Metalloproteases
references.citation: Nature. 2001 May 17;411(6835):375-9
references.pmid: 11357145
references.citation: Nat Rev Cancer. 2004 Nov;4(11):839-49
references.pmid: 15516957
references.citation: Annu Rev Cell Biol. 1993;9:541-73
references.pmid: 8280471
references.citation: Lancet. 1988 Jul 16;2(8603):135-7
references.pmid: 2899190
references.citation: Breast Cancer Res. 2003;5(3):130-5
references.pmid: 12793893
references.citation: J Cell Physiol. 2002 Sep;192(3):259-67
references.pmid: 12124771
references.citation: Mol Imaging. 2003 Jul;2(3):159-75
references.pmid: 14649059
references.citation: J Gastroenterol Hepatol. 2003 Jun;18(6):666-72
references.pmid: 12753148
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Math Biosci. 2002 Nov-Dec;180:307-28
references.pmid: 12387930
references.citation: Nat Med. 1997 Feb;3(2):177-82
references.pmid: 9018236
references.citation: Virchows Arch. 1997 Jun;430(6):433-43
references.pmid: 9230908
references.citation: Science. 1997 Jul 11;277(5323):225-8
references.pmid: 9211848
references.citation: Neoplasia. 2003 Mar-Apr;5(2):135-45
references.pmid: 12659686
references.citation: Cancer Res. 1996 Dec 15;56(24):5745-53
references.pmid: 8971186
references.citation: Nat Rev Cancer. 2004 Nov;4(11):891-9
references.pmid: 15516961
references.citation: Clin Exp Metastasis. 1989 May-Jun;7(3):277-82
references.pmid: 2647331
references.citation: Int J Cancer. 2003 Dec 10;107(5):688-95
references.pmid: 14566816
references.citation: Gastrointest Radiol. 1990 Summer;15(3):233-7
references.pmid: 2160391
references.citation: Biochimie. 2005 Mar-Apr;87(3-4):321-8
references.pmid: 15781319
references.citation: Gen Diagn Pathol. 1997 Feb;142(3-4):155-63
references.pmid: 9065579
references.citation: Trends Cell Biol. 2001 Nov;11(11):S37-43
references.pmid: 11684441
references.citation: Cancer. 1992 Jul 1;70(1):45-9
references.pmid: 1318778
references.citation: J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S
references.pmid: 18523064
references.citation: Cell. 1997 Nov 14;91(4):439-42
references.pmid: 9390552
references.citation: Cancer Res. 1989 Aug 15;49(16):4373-84
references.pmid: 2545340
references.citation: Cancer Res. 2006 May 15;66(10):5216-23
references.pmid: 16707446
references.citation: Eur J Cancer. 1999 Aug;35(8):1274-80
references.pmid: 10615241
references.citation: Breast Cancer Res Treat. 1997 Apr;43(2):175-81
references.pmid: 9131273
references.citation: Nat Rev Cancer. 2001 Oct;1(1):46-54
references.pmid: 11900251
references.citation: Math Biosci. 2009 Jul;220(1):45-56
references.pmid: 19376138
references.citation: J Pathol. 2003 Jul;200(4):429-47
references.pmid: 12845611
references.citation: Cancer. 2006 Apr 15;106(8):1669-76
references.pmid: 16534796
references.citation: Int J Biochem Cell Biol. 2007;39(7-8):1358-66
references.pmid: 17499003
references.citation: Semin Cancer Biol. 2000 Dec;10(6):415-33
references.pmid: 11170864
references.citation: Clin Exp Metastasis. 1999 Jul;17(5):397-407
references.pmid: 10651306
references.citation: Cancer Res. 2003 Jul 15;63(14):3847-54
references.pmid: 12873971